C12N 2710/16651
Methods of production or purification of viral material
C12N2710/16651 (Methods of production or purification of viral material) appears on 63 US grants and 92 published applications in this corpus.
Search patents in C12N- Granted patents
- 63
- Published applications
- 92
- Assignees
- 67
- Inventors
- 165
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 1 |
| 2002 | 1 | 1 |
| 2003 | 0 | 2 |
| 2004 | 0 | 3 |
| 2005 | 1 | 2 |
| 2006 | 0 | 2 |
| 2007 | 3 | 4 |
| 2008 | 0 | 3 |
| 2009 | 0 | 3 |
| 2010 | 1 | 0 |
| 2011 | 1 | 2 |
| 2012 | 3 | 3 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 2 | 3 |
| 2016 | 2 | 6 |
| 2017 | 3 | 3 |
| 2018 | 3 | 4 |
| 2019 | 5 | 8 |
| 2020 | 3 | 6 |
| 2021 | 2 | 3 |
| 2022 | 6 | 10 |
| 2023 | 2 | 5 |
| 2024 | 3 | 5 |
| 2025 | 6 | 8 |
| 2026 | 3 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Recombinant oncolytic virus, preparation method therefor, use thereof and medicine thereof26 May 2026US 12,636,329 B2
- Herpesvirus with modified glycoprotein H for propagation in a cell21 Apr 2026US 12,606,801 B2Alma Matter Studiorum Universita Di Bologna
- Replication-competent recombinant herpes simplex virus type 1 (HSV-1) comprising deletions in the ICP6 and IR regions14 Apr 2026US 12,600,955 B1Sungkwang Medical Foundation
- Method for producing a virus and a harvesting solution composition2 Dec 2025US 12,486,487 B2Hangzhou Converd Co., Ltd.
- Syncytial oncolytic herpes simplex mutants as potent cancer therapeutics25 Nov 2025US 12,480,097 B2Research Institute At Nationwide Children's Hospital
- High-transducing hsv vectors10 Sep 2026US 2026/0265775 A1PeriphaGen, Inc.
- Compositions and systmes for herpes simplex virus packaging and uses thereof28 May 2026US 2026/0146259 A1Opentrons Labworks Inc.
- Herpesvirus compositions and related methods8 Jan 2026US 2026/0007739 A1Sanofi Pasteur Limited
- Recombinant herpes simplex virus-2 expressing glycoprotein d and b antigens4 Dec 2025US 2025/0367279 A1The Brigham and Women S Hospital, Inc.
- Modified Herpes Simplex Virus Type 16 Nov 2025US 2025/0340903 A1Eg 427
Most cited
By later US patents
- Herpes Simplex virus as a vector100US 5,288,641 AArch Development Corporation · 1994
- Production of orthomyxoviruses in monkey kidney cells using protein-free media88US 6,146,873 ABaxter Aktiengesellschaft · 2000
- Herpes simplex virus strains for gene transfer71US 5,804,413 AUniversity of Pittsburgh—Of the Commonwealth System of Higher Education · 1998
- Methods for producing preparations of recombinant AAV virions substantially free of empty capsids69US 8,137,948 B2Genzyme Corporation · 2012
- Dendritic-marker expressing macrophage cultures and methods of reactivating latent virus68US 6,225,048 B1Oregon Health Sciences University · 2001